Better diagnostic testing for interstitial lung disease
Part of Lungs & breathing clinical trials.
This research study tests new diagnostic methods to better identify and predict outcomes in interstitial lung disease (a group of lung conditions causing scarring and breathing problems). Researchers are looking for people with ILD or those exposed to pigeons, which can trigger a type of lung disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have interstitial lung disease (ILD) being treated at an ILD clinic, OR you were hospitalized with severe breathing failure from ILD
- OR you are an active pigeon fancier (someone who keeps or breeds pigeons regularly)
- You are able to understand the study and give your informed consent to participate
- You do not have a condition preventing you from giving informed consent (such as severe cognitive impairment)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing a new way to speed up the diagnosis of interstitial lung disease (a group of lung scarring conditions). If you have symptoms or scan findings that suggest ILD but haven't been fully diagnosed yet, this trial may help you get a faster, clearer answer.
This study looks at how to find and treat fibrotic interstitial lung disease (a condition where lung tissue becomes scarred and stiff) as early as possible. It may help people with this type of lung disease get better care.
This trial tests a new way to organize follow-up visits for people with interstitial lung disease (a group of lung conditions). It aims to make care simpler and more effective for patients who are already on treatment.
This trial checks how safe a lung biopsy (a small sample taken with a needle) is for people with interstitial lung disease, a condition that causes scarring in the lungs. The goal is to see if the biopsy can be done with fewer risks when guided by ultrasound.
This trial is for adults with interstitial lung disease (a group of lung conditions that cause scarring). It aims to understand the disease better and may help find new ways to treat it.
This study aims to improve how doctors diagnose and classify lung conditions that affect both the air sacs and airways, such as COPD and pulmonary fibrosis. By participating, you may help advance medical knowledge and better understand your own condition.
Hear when a new Interstitial Lung Disease (ILD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.